CytoMed Therapeutics (GDTC) Shares Outstanding (2024 - 2025)
CytoMed Therapeutics (GDTC) has disclosed Shares Outstanding for 2 consecutive years, with $9.1 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding rose 5.2% to $9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, up 5.2% year-over-year, with the annual reading at $9.1 million for FY2025, 4.8% up from the prior year.
- Shares Outstanding hit $9.1 million in Q4 2025 for CytoMed Therapeutics, up from $8.7 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $9.1 million in Q4 2025 to a low of $8.7 million in Q4 2024.